Treatment for hepatitis B involves inhibiting viral replication, thereby reducing the amount of liver inflammation. This can slow the disease’s progression and decelerate the onset of liver cirrhosis or liver cancer. Additionally, some treatments can reduce liver fibrosis.
It is crucial for hepatitis B patients to understand that not all chronic hepatitis B sufferers are suited for treatment, and that special consideration will be given to cases where the virus is spreading, liver inflammation is occurring, or for those with existing liver disorders. There are some points at which the disease is more responsive to treatment, meaning the doctor will consider treating patients who possess certain key indicators.
The doctor will be responsible for determining when antiviral medication treatment can be discontinued, using a number of key indicators to make that decision. Current treatment techniques mean that some patients may be required to take medication for the long-term, or even for the remainder of their lives. Patients should not be the ones who decide when to halt their medication. Medical staff will also monitor the situation of patients who do not yet require such treatment to enable a rapid response should any indicators become apparent, as well as to enable early detection for the onset of liver cancer.